動物用整形生物工学の世界市場：市場規模、シェア、動向分析 - 送達形態別、製品別、動物別、用途別、最終用途別、地域別、セグメント予測、2024～2030年

動物用整形生物工学市場の成長と動向：

世界の動物用整形生物工学の市場規模は、2024～2030年にかけてCAGR 8.82％を記録し、2030年には12億4,000万米ドルに達すると予測されています。

市場成長を促進する2つの重要な要因は、整形生物工学の臨床試験数の増加と、動物における整形外科的合併症の有病率の上昇です。業界では近年、動物用整形外科合併症の治療における新規の整形生物学的製剤の臨床試験が着実に増加しています。例えば、2024年6月、米国FDAは犬と馬を対象とした幹細胞臨床試験の開始を承認しました。この臨床試験はコーネル大学動物病院（CUHA）が実施します。この研究では、イヌとウマの神経および筋骨格系の合併症の治療における幹細胞の有効性が検討されます。この研究では、参加者の同系脂肪または骨髄由来の間葉系幹細胞を抽出し、神経、筋肉、その他の疾患の治療に使用します。

この研究から集められたデータは、獣医再生医療における臨床的根拠に基づいた製品の開発に役立ちます。さらに、Cell Therapy Toolsは2024年6月にも臨床試験を開始しました。前臨床試験において、同社の製品であるクロンドロシールドは、参加者の犬たちに良好な反応を示し、副作用なくOAに改善を示しました。この最新の臨床試験段階は、さらなる試験のために、より多くのイヌの参加者を募集することを目的としています。この製品は、犬の血小板内のサイトカインと成長因子を利用して、患部の治癒反応を引き起こし、軟骨の修復を助ける。このような継続的な進歩は、市場が多くの成長機会とともに常に進化し続けていることを示しています。このような研究は、徹底的に精査されたエビデンスを基に、整形外科疾患を治療するための新規製品を生み出すのに役立っており、市場に大きな成長見通しをもたらしています。

さらに、世界中で、整形外科疾患は動物でますます一般的になってきています。例えば、2024年にPlos Oneで発表された研究によると、複数の研究者が協力して「犬の老化プロジェクト」を開始し、生涯を通じて犬の疾患パターンをマッピングし、理解することに成功しました。このプロジェクトでは、整形外科疾患の有病率は、治療せずに放置した場合、犬の年齢が進むにつれて増加することが判明しました。また、体重が30kg以上の犬ほど整形外科的疾患の有病率が高く（23％）、肥満と整形外科的疾患の相関関係が証明されました。さらに、2023年にNCBIで発表された論文によると、猫における変形性関節症（OA）の有病率は約60％と推定されています。OAと診断されたものは、関節痛、関節の変形、跛行などの関連症状に悩まされていると報告されています。これらの症状は、太りすぎの猫に多く見られることが判明しました。これらの要因はすべて、動物の整形外科的合併症の増加を治療するために、幹細胞、多血小板血漿（PRP）、モノクローナル抗体（mAb）のような適切な整形生物学的製剤が必要であることを示しています。

動物用整形生物工学市場レポートハイライト

• PRP製品セグメントは、2023年に39.2%の最大収益シェアを占めました。動物では、血小板は免疫反応、血管新生、組織修復などの複数のプロセスで不可欠です。PRPは、新しい組織の成長を速めることによって腱や靭帯の治癒を速めるタンパク質＆成長因子を含むため、血液凝固の治癒プロセスを促進するために採用されています。
• イヌの動物セグメントは、高い採用率、イヌのスポーツ関連ケガの症例の増加、イヌのOA有病率の高さ（40％）およびイヌの5頭に1頭の跛行（Zoetis、2024年データ）により、2023年に46.1％のシェアで市場を独占しました。
• OA用途セグメントは、犬、猫、馬におけるOAの高い有病率とOAの寄与要因の増加により、2023年に60％以上のシェアで市場を独占しました。OAは動物で最も一般的な疾患の1つになりつつあります。OAの主な原因因子は、肥満、犬種、運動不足と適切な食事、遺伝的素因などです。
• 2023年の市場は、関節内投与モードセグメントが支配的でした。この優位性は、関節内に直接投与することで、より迅速な作用と薬物のバイオアベイラビリティを向上させることができるため、その需要が高いことに起因しています。獣医学では、関節生物学的製剤の関節内投与は、関節の疼痛や跛行を管理するための確立されたプロセスです。
• 最終用途に基づくと、動物病院で動物の整形外科疾患の治療を受ける患者数が増加しているため、2023年には動物病院セグメントがシェアで市場を独占しました。必要な場所で整形生物学的製剤を投与するには、特定の機器と熟練したスタッフが不可欠です。全体として、病院の薬局で治療法、熟練したスタッフ、専門機器を一箇所で利用できることは、動物の飼い主にとって有利です。
• 北米は2023年に43.23%の最大シェアを占めました。この優位性は、ペットの飼育率の高さ、飼い主の動物健康意識の高さ、動物健康への支出の増加、Zoetis、VetStem Inc.、Enso Discoveries、Ardent Animal Healthなどの大手企業の存在に起因します。
• アジア太平洋市場は、日本、中国、インドなどの主要国における研究開発活動の創意工夫の増加により、2024年から2030年にかけて10.09%以上の最高のCAGRで成長すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 動物用整形生物工学市場の変動動向と範囲

• 市場系統の見通し
• 市場力学
• 動物用整形生物工学市場分析ツール

第4章 動物用整形生物工学市場：製品の推定・動向分析

• セグメントダッシュボード
• 動物用整形生物工学市場：製品の変動分析
• 動物用整形生物工学の市場規模と動向分析、製品別、2018～2030年
• 幹細胞
• 多血小板血漿（PRP）
• その他の生物製剤

第5章 動物用整形生物工学市場：動物の推定・動向分析

• セグメントダッシュボード
• 動物用整形生物工学市場：動物の変動分析
• 動物用整形生物工学の市場規模と動向分析、動物別、2018～2030年
• 犬
• 馬
• その他

第6章 動物用整形生物工学市場：用途の推定・動向分析

• セグメントダッシュボード
• 動物用整形生物工学市場：用途の変動分析
• 動物用整形生物工学の市場規模と動向分析、用途別、2018～2030年
• 変形性関節症
• 変形性関節症
• その他の用途

第7章 動物用整形生物工学市場：送達形態の推定・動向分析

• セグメントダッシュボード
• 動物用整形生物工学市場：送達形態の変動分析
• 動物用整形生物工学の市場規模と動向分析、送達形態別、2018～2030年

第8章 動物用整形生物工学市場：最終用途の推定・動向分析

• セグメントダッシュボード
• 動物用整形生物工学市場：最終用途の変動分析
• 動物用整形生物工学の市場規模と動向分析、最終用途別、2018～2030年

第9章 動物用整形生物工学市場：地域の推定・動向分析

• 地域ダッシュボード
• 動物用整形生物工学市場シェア、地域別、2023年・2030年、100万米ドル
• 地域展望
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 市場参入企業の分類
• 企業市況分析/ヒープマップ分析
• 企業プロファイル
  • Zoetis
  • Boehringer Ingelheim
  • Ardent Animal Health Llc.
  • Enso Discoveries
  • VetStem Inc.
  • Medrego Llc
  • T-Cyte Therapeutics
  • Arthrex Inc.
  • Hilltop Bio
  • Enovis
  • Movora
  • Dechra Pharmaceuticals Llc.
• 戦略マッピング
  • 合併と買収
  • パートナーシップとコラボレーション
  • 拡大
  • 製品発売
  • 製品承認
  • その他
• 主要企業一覧
• メーカー一覧
  • 販売代理店一覧

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 4 Global Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 5 Global Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 6 Global Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 7 Global Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 8 Global Veterinary Orthobiologics Market, by Region, 2018 - 2030 (USD Million)
• Table 9 North America Veterinary Orthobiologics Market, by Country, 2018 - 2030 (USD Million)
• Table 10 North America Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 11 North America Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 12 North America Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 13 North America Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 14 North America Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 15 U.S. Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 16 U.S. Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 17 U.S. Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 18 U.S. Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 19 U.S. Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 20 Canada Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 21 Canada Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 22 Canada Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 23 Canada Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 24 Canada Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 25 Mexico Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 26 Mexico Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 27 Mexico Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 28 Mexico Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 29 Mexico Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 30 Europe Veterinary Orthobiologics Market, by Country, 2018 - 2030 (USD Million)
• Table 31 Europe Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 32 Europe Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 33 Europe Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 34 Europe Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 35 Europe Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 36 Germany Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 37 Germany Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 38 Germany Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 39 Germany Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 40 Germany Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 41 UK Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 42 UK Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 43 UK Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 44 UK Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 45 UK Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 46 France Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 47 France Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 48 France Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 49 France Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 50 France Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 51 Italy Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 52 Italy Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 53 Italy Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 54 Italy Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 55 Italy Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 56 Spain Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 57 Spain Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 58 Spain Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 59 Spain Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 60 Spain Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 61 Denmark Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 62 Denmark Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 63 Denmark Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 64 Denmark Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 65 Denmark Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 66 Sweden Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 67 Sweden Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 68 Sweden Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 69 Sweden Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 70 Sweden Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 71 Norway Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 72 Norway Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 73 Norway Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 74 Norway Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 75 Norway Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 76 Asia Pacific Veterinary Orthobiologics Market, by Country, 2018 - 2030 (USD Million)
• Table 77 Asia Pacific Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 78 Asia Pacific Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 79 Asia Pacific Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 80 Asia Pacific Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 81 Asia Pacific Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 82 China Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 83 China Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 84 China Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 85 China Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 86 China Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 87 Japan Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 88 Japan Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 89 Japan Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 90 Japan Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 91 Japan Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 92 India Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 93 India Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 94 India Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 95 India Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 96 India Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 97 South Korea Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 98 South Korea Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 99 South Korea Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 100 South Korea Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 101 South Korea Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 102 Australia Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 103 Australia Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 104 Australia Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 105 Australia Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 106 Australia Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 107 Thailand Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 108 Thailand Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 109 Thailand Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 110 Thailand Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 111 Thailand Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 112 Latin America Veterinary Orthobiologics Market, by Country, 2018 - 2030 (USD Million)
• Table 113 Latin America Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 114 Latin America Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 115 Latin America Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 116 Latin America Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 117 Latin America Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 118 Brazil Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 119 Brazil Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 120 Brazil Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 121 Brazil Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 122 Brazil Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 123 Argentina Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 124 Argentina Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 125 Argentina Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 126 Argentina Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 127 Argentina Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 128 Middle East & Africa Veterinary Orthobiologics Market, by Country, 2018 - 2030 (USD Million)
• Table 129 Middle East & Africa Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 130 Middle East & Africa Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 131 Middle East & Africa Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 132 Middle East & Africa Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 133 Middle East & Africa Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 134 South Africa Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 135 South Africa Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 136 South Africa Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 137 South Africa Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 138 South Africa Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 139 Saudi Arabia Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 140 Saudi Arabia Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 141 Saudi Arabia Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 142 Saudi Arabia Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 143 Saudi Arabia Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 144 UAE Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 145 UAE Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 146 UAE Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 147 UAE Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 148 UAE Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)
• Table 149 Kuwait Veterinary Orthobiologics Market, By Product, 2018 - 2030 (USD Million)
• Table 150 Kuwait Veterinary Orthobiologics Market, By Animal, 2018 - 2030 (USD Million)
• Table 151 Kuwait Veterinary Orthobiologics Market, By Application, 2018 - 2030 (USD Million)
• Table 152 Kuwait Veterinary Orthobiologics Market, By Mode of Delivery, 2018 - 2030 (USD Million)
• Table 153 Kuwait Veterinary Orthobiologics Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Veterinary Orthobiologics Market, Market Segmentation
• Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Regional Marketplace: Key Takeaways
• Fig. 14 Global Veterinary Orthobiologics Market, for Product, 2018 - 2030 (USD Million)
• Fig. 15 Global Veterinary Orthobiologics Market, for Stem Cells, 2018 - 2030 (USD Million)
• Fig. 16 Global Veterinary Orthobiologics Market, for Platelet-Rich Plasma (PRP), 2018 - 2030 (USD Million)
• Fig. 17 Global Veterinary Orthobiologics Market, for Other Biologics, 2018 - 2030 (USD Million)
• Fig. 18 Global Veterinary Orthobiologics Market, for Animal, 2018 - 2030 (USD Million)
• Fig. 19 Global Veterinary Orthobiologics Market, for Canine, 2018 - 2030 (USD Million)
• Fig. 20 Global Veterinary Orthobiologics Market, for Equine, 2018 - 2030 (USD Million)
• Fig. 21 Global Veterinary Orthobiologics Market, for Other Animals, 2018 - 2030 (USD Million)
• Fig. 22 Global Veterinary Orthobiologics Market, for Application, 2018 - 2030 (USD Million)
• Fig. 23 Global Veterinary Orthobiologics Market, for Osteoarthritis, 2018 - 2030 (USD Million)
• Fig. 24 Global Veterinary Orthobiologics Market, for Degenerative Joint Disease (DJD), 2018 - 2030 (USD Million)
• Fig. 25 Global Veterinary Orthobiologics Market, for Other Applications, 2018 - 2030 (USD Million)
• Fig. 26 Global Veterinary Orthobiologics Market, for Mode of Delivery, 2018 - 2030 (USD Million)
• Fig. 27 Global Veterinary Orthobiologics Market, for Intra-muscular/Intra-lesional, 2018 - 2030 (USD Million)
• Fig. 28 Global Veterinary Orthobiologics Market, for Intra-articular, 2018 - 2030 (USD Million)
• Fig. 29 Global Veterinary Orthobiologics Market, for Other Modes, 2018 - 2030 (USD Million)
• Fig. 30 Global Veterinary Orthobiologics Market, for End Use, 2018 - 2030 (USD Million)
• Fig. 31 Global Veterinary Orthobiologics Market, for Veterinary Hospitals, 2018 - 2030 (USD Million)
• Fig. 32 Global Veterinary Orthobiologics Market, for Veterinary Clinics, 2018 - 2030 (USD Million)
• Fig. 33 Global Veterinary Orthobiologics Market, for Other end-use, 2018 - 2030 (USD Million)
• Fig. 34 Regional Outlook, 2023 & 2030
• Fig. 35 North America Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 36 U.S. Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 37 Canada Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 38 Mexico Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 39 Europe Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 40 Germany Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 41 UK Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 42 France Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 43 Italy Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 44 Spain Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 45 Denmark Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 46 Sweden Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 47 NorwayVeterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 48 Asia Pacific Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 49 Japan Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 50 China Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 51 India Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 52 Australia Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 53 South Korea Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 54 Thailand Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 55 Latin America Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 56 Brazil Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 57 Argentina Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 58 Middle East and Africa Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 59 South Africa Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 60 Saudi Arabia Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 61 UAE Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)
• Fig. 62 Kuwait Veterinary Orthobiologics Market, 2018 - 2030 (USD Million)

Veterinary Orthobiologics Market Growth & Trends:

The global veterinary orthobiologics market size is expected to reach USD 1.24 billion by 2030, registering a CAGR of 8.82% from 2024 to 2030, according to a new report by Grand View Research, Inc. Two crucial factors driving the market growth are the increasing number of clinical trials in orthobiologics and the rising prevalence of orthopedic complications in animals. The industry has experienced a steady rise in clinical trials for novel orthobiologics in treating veterinary orthopedic complications in recent years. For instance, in June 2024, the U.S. FDA approved initiating stem cell clinical trials for dogs & horses. This trial will be conducted by Cornell University Hospital for Animals (CUHA). It will explore the effectiveness of stem cells in treating neurological and musculoskeletal complications in canine & equine species. The study will extract the participants' allogenic adipose or bone marrow-derived mesenchymal stem cells and use them to treat nerve, muscle, and other conditions.

The data gathered from this study will help develop clinical evidence-based products in veterinary regenerative medicine. Furthermore, Cell Therapy Tools initiated another clinical trial in June 2024. In the pre-clinical studies, the company's product, Chrondroshield, the participants' dogs responded well to the therapy, showing improvements in OA without side effects. This latest clinical trial phase aims to recruit more canine participants for further testing. This product uses cytokine and growth factors inside the dog's platelets to trigger a healing response in the affected area and assist in cartilage repair. These ongoing advancements showcase the market's ever-evolving nature, with many growth opportunities. Studies like these help create novel products for treating orthopedic conditions with a thoroughly scrutinized base of evidence, providing the market with substantial growth prospects.

In addition, throughout the globe, orthopedic conditions are becoming increasingly common in animals. For instance, according to a 2024 Plos One published study, multiple researchers collaborated to initiate a "Dog Aging Project" to map out and understand disease patterns in dogs throughout their lives. The project determined that the prevalence of orthopedic conditions, if left untreated, increases as the age of the dogs progresses, i.e., prevalence at age 1 - 1% and prevalence at age 11 & above - 39%. The dogs with higher weight, i.e., more than 30 kgs, were determined to have a higher prevalence of orthopedic conditions (23%), thus establishing a correlation between obesity and orthopedic diseases. Furthermore, according to a 2023 publication in NCBI, the prevalence of Osteoarthritis (OA) in cats was estimated at around 60%. Those diagnosed with OA were reported to be suffering from associated conditions, such as joint pain, joint deformity, lameness, etc. These symptoms were determined to be on the higher side in overweight cats. All these factors collectively point toward the need for appropriate orthobiologics like stem cells, platelet-rich plasma (PRP), and monoclonal antibody (mAb) to treat this rise in orthopedic complications in animals.

Veterinary Orthobiologics Market Report Highlights:

• The PRP product segment accounted for the largest revenue share of 39.2% in 2023. In animals, platelets are vital in multiple processes, such as immune response, angiogenesis, and tissue repair. PRP is employed to promote the healing process in blood clotting as it contains proteins & growth factors that speed up the healing of the tendons & ligaments by speeding up the growth of new tissues
• The canine animal segment dominated the market with a share of 46.1% in 2023 due to the high adoption rate, rising cases of sports-related injuries in dogs, and high prevalence of OA in dogs (40%) and lameness in 1 in 5 dogs (Zoetis, 2024 data)
• The OA application segment dominated the market with a share of over 60% in 2023 because of the high prevalence of OA and rise in contributing factors to OA in dogs, cats, and horses. OA is becoming one of the most prevalent conditions in animals. The main causative factors for OA can be obesity, breed, lack of exercise & proper diet, and genetic predisposition
• The intra-articular delivery mode segment dominated the market in 2023. This dominance can be attributed to its demand as it can be directly delivered into the joint to ensure faster action and increase drug bioavailability. In veterinary medicine, intra-articular administration of orthobiologics is an established process for managing joint pain and lameness
• Based on the end use, the veterinary hospitals segment dominated the market in terms of share in 2023 due to the increased number of patients receiving treatment for orthopedic medical conditions in animals at these hospitals. To administer orthobiologics at the necessary location, specific equipment and skilled staff are essential. Overall, the availability of therapies, skilled personnel, and specialized equipment at the hospital pharmacy in a single location is advantageous to animal owners
• North America accounted for the largest share of 43.23% in 2023. This dominance can be attributed to the high pet adoption rate, higher animal health awareness among owners, rising spending on animal health, and the presence of major companies, such as Zoetis, VetStem Inc., Enso Discoveries, and Ardent Animal Health
• The Asia Pacific APAC regional market is expected to grow at the highest CAGR of over 10.09% from 2024 to 2030 due to increasing ingenuity in R&D activities in major countries like Japan, China, and India

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Veterinary Orthobiologics Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Advances in Veterinary Regenerative Medicine
    • 3.2.1.2. Rising Prevalence of Orthopedic Complications in Animals
    • 3.2.1.3. Global Rise in Animal Athletic Events
    • 3.2.1.4. Rising Innovative Product Launches
    • 3.2.1.5. Increasing Number of Clinical Trials
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Underdiagnosis of Orthopedic Complications
    • 3.2.2.2. Misleading Practices by Industry Players
    • 3.2.2.3. Product Limitations
    • 3.2.2.4. Lack of Clinical Evidence
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Veterinary Orthobiologics Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
  • 3.3.3. Regulatory Framework
  • 3.3.4. Estimated Animal Population, by Key Species, by Key Countries, 2018-2023
  • 3.3.5. Clinical Trials Analysis
  • 3.3.6. Pricing Analysis
  • 3.3.7. COVID-19 Impact Analysis

Chapter 4. Veterinary Orthobiologics Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Veterinary Orthobiologics Market: Product Movement Analysis
• 4.3. Veterinary Orthobiologics Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
• 4.4. Stem Cells
  • 4.4.1. Stem Cells Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Platelet-Rich Plasma (PRP)
  • 4.5.1. Platelet-Rich Plasma (PRP) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Other Biologics
  • 4.6.1. Other Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Orthobiologics Market: Animal Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Veterinary Orthobiologics Market: Animal Movement Analysis
• 5.3. Veterinary Orthobiologics Market Size & Trend Analysis, by animal, 2018 to 2030 (USD Million)
• 5.4. Canine
  • 5.4.1. Canine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Equine
  • 5.5.1. Equine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Orthobiologics Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Veterinary Orthobiologics Market: Application Movement Analysis
• 6.3. Veterinary Orthobiologics Market Size & Trend Analysis, by application, 2018 to 2030 (USD Million)
• 6.4. Osteoarthritis
  • 6.4.1. Osteoarthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Degenerative Joint Disease
  • 6.5.1. Degenerative Joint Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Other Applications
  • 6.6.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Orthobiologics Market: By Mode of Delivery Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Veterinary Orthobiologics Market: By Mode of Delivery Movement Analysis
• 7.3. Veterinary Orthobiologics Market Size & Trend Analysis, by mode of delivery, 2018 to 2030 (USD Million)
  • 7.3.1. Intra-muscular/Intra-lesional
    • 7.3.1.1. Intra-muscular/Intra-lesional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. Intra-articular
    • 7.3.2.1. Intra-articular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Other Modes
    • 7.3.3.1. Other Modes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Veterinary Orthobiologics Market: By End Use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Veterinary Orthobiologics Market: By End Use Movement Analysis
• 8.3. Veterinary Orthobiologics Market Size & Trend Analysis, by end use, 2018 to 2030 (USD Million)
  • 8.3.1. Veterinary Hospitals
    • 8.3.1.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. Veterinary Clinics
    • 8.3.2.1. Veterinary Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.3. Others
    • 8.3.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Veterinary Orthobiologics Market: Regional Estimates & Trend Analysis

• 9.1. Regional Dashboard
• 9.2. Veterinary Orthobiologics Market Share, By Region, 2023 & 2030, USD Million
• 9.3. Regional Outlook
• 9.4. North America
  • 9.4.1. North America Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.2. U.S.
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Competition Insights
    • 9.4.2.3. U.S. Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.3. Canada
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Competition Insights
    • 9.4.3.3. Canada Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.4. Mexico
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Competition Insights
    • 9.4.4.3. Mexico Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.5. Europe
  • 9.5.1. Europe Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.2. UK
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Competition Insights
    • 9.5.2.3. UK Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.3. Germany
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Competition Insights
    • 9.5.3.3. Germany Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.4. France
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Competition Insights
    • 9.5.4.3. France Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.5. Italy
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Competition Insights
    • 9.5.5.3. Italy Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.6. Spain
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Competition Insights
    • 9.5.6.3. Spain Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.7. Denmark
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Competition Insights
    • 9.5.7.3. Denmark Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.8. Sweden
    • 9.5.8.1. Key Country Dynamics
    • 9.5.8.2. Competition Insights
    • 9.5.8.3. Sweden Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.9. Norway
    • 9.5.9.1. Key Country Dynamics
    • 9.5.9.2. Competition Insights
    • 9.5.9.3. Norway Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.6. Asia Pacific
  • 9.6.1. Asia Pacific Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.2. Japan
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Competition Insights
    • 9.6.2.3. Japan Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.3. China
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Competition Insights
    • 9.6.3.3. China Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.4. India
    • 9.6.4.1. Key Country Dynamics
    • 9.6.4.2. Competition Insights
    • 9.6.4.3. India Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.5. Australia
    • 9.6.5.1. Key Country Dynamics
    • 9.6.5.2. Competition Insights
    • 9.6.5.3. Australia Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.6. South Korea
    • 9.6.6.1. Key Country Dynamics
    • 9.6.6.2. Competition Insights
    • 9.6.6.3. South Korea Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.7. Thailand
    • 9.6.7.1. Key Country Dynamics
    • 9.6.7.2. Competition Insights
    • 9.6.7.3. Thailand Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.7. Latin America
  • 9.7.1. Latin America Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.2. Brazil
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Competition Insights
    • 9.7.2.3. Brazil Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030
  • 9.7.3. Argentina
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Competition Insights
    • 9.7.3.3. Argentina Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.8. Middle East & Africa
  • 9.8.1. Middle East & Africa Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.2. South Africa
    • 9.8.2.1. Key Country Dynamics
    • 9.8.2.2. Competition Insights
    • 9.8.2.3. South Africa Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.3. Saudi Arabia
    • 9.8.3.1. Key Country Dynamics
    • 9.8.3.2. Competition Insights
    • 9.8.3.3. Saudi Arabia Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.4. UAE
    • 9.8.4.1. Key Country Dynamics
    • 9.8.4.2. Competition Insights
    • 9.8.4.3. UAE Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.5. Kuwait
    • 9.8.5.1. Key Country Dynamics
    • 9.8.5.2. Competition Insights
    • 9.8.5.3. Kuwait Veterinary Orthobiologics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Market Participant Categorization
• 10.2. Company Market Position Analysis/ Heap Map Analysis
• 10.3. Company Profiles
  • 10.3.1. Zoetis
    • 10.3.1.1. Participant's Overview
    • 10.3.1.2. Financial Performance
    • 10.3.1.3. Product Benchmarking
    • 10.3.1.4. Strategic Initiatives
  • 10.3.2. Boehringer Ingelheim
    • 10.3.2.1. Participant's Overview
    • 10.3.2.2. Financial Performance
    • 10.3.2.3. Product Benchmarking
    • 10.3.2.4. Strategic Initiatives
  • 10.3.3. Ardent Animal Health Llc.
    • 10.3.3.1. Participant's Overview
    • 10.3.3.2. Financial Performance
    • 10.3.3.3. Product Benchmarking
    • 10.3.3.4. Strategic Initiatives
  • 10.3.4. Enso Discoveries
    • 10.3.4.1. Participant's Overview
    • 10.3.4.2. Financial Performance
    • 10.3.4.3. Product Benchmarking
    • 10.3.4.4. Strategic Initiatives
  • 10.3.5. VetStem Inc.
    • 10.3.5.1. Participant's Overview
    • 10.3.5.2. Financial Performance
    • 10.3.5.3. Product Benchmarking
    • 10.3.5.4. Strategic Initiatives
  • 10.3.6. Medrego Llc
    • 10.3.6.1. Participant's Overview
    • 10.3.6.2. Financial Performance
    • 10.3.6.3. Product Benchmarking
    • 10.3.6.4. Strategic Initiatives
  • 10.3.7. T-Cyte Therapeutics
    • 10.3.7.1. Participant's Overview
    • 10.3.7.2. Financial Performance
    • 10.3.7.3. Product Benchmarking
    • 10.3.7.4. Strategic Initiatives
  • 10.3.8. Arthrex Inc.
    • 10.3.8.1. Participant's Overview
    • 10.3.8.2. Financial Performance
    • 10.3.8.3. Product Benchmarking
    • 10.3.8.4. Strategic Initiatives
  • 10.3.9. Hilltop Bio
    • 10.3.9.1. Participant's Overview
    • 10.3.9.2. Financial Performance
    • 10.3.9.3. Product Benchmarking
    • 10.3.9.4. Strategic Initiatives
  • 10.3.10. Enovis
    • 10.3.10.1. Participant's Overview
    • 10.3.10.2. Financial Performance
    • 10.3.10.3. Product Benchmarking
    • 10.3.10.4. Strategic Initiatives
  • 10.3.11. Movora
    • 10.3.11.1. Participant's Overview
    • 10.3.11.2. Financial Performance
    • 10.3.11.3. Product Benchmarking
    • 10.3.11.4. Strategic Initiatives
  • 10.3.12. Dechra Pharmaceuticals Llc.
    • 10.3.12.1. Participant's Overview
    • 10.3.12.2. Financial Performance
    • 10.3.12.3. Product Benchmarking
    • 10.3.12.4. Strategic Initiatives
• 10.4. Strategy Mapping
  • 10.4.1. Mergers & Acquisitions
  • 10.4.2. Partnerships & Collaborations
  • 10.4.3. Expansion
  • 10.4.4. Product launch
  • 10.4.5. Product Approval
  • 10.4.6. Others
• 10.5. List of Key Companies
• 10.6. List of Manufacturers
  • 10.6.1. List of Distributors